Choice of lipid-lowering drugs.
D000818:Animals; D002792:Cholestyramine Resin / Q000627:therapeutic use; D003327:Coronary Disease / Q000188:drug therapy; D015914:Estrogen Replacement Therapy; D015248:Gemfibrozil / Q000627:therapeutic use; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D000960:Hypolipidemic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D008074:Lipoproteins / Q000097:blood; D009525:Niacin / Q000627:therapeutic use
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D000960:Hypolipidemic Agents; D008074:Lipoproteins; D002792:Cholestyramine Resin; D009525:Niacin; D015248:Gemfibrozil